Background/Aims: Ergosterol (ER) is the primary sterol found in fungi and is named after the ergot fungus. A variety of pharmacological activities have been reported for ER, including antioxidative, anti-proliferative, and anti-inflammatory effects, although its role in sepsis remains unclear. Methods: The protective effect of ER on lipopolysaccharide (LPS)-induced sepsis myocardial injury was evaluated both in vivo and in vitro. Rats were pretreated with ER and then with LPS. Histopathology of heart tissues was first performed. Subsequently, the levels of superoxide dismutase (SOD), malondialdehyde (MDA), creatine kinase MB fraction (CK-MB), and lactate dehydrogenase (LDH) in serum and heart tissues were assessed by enzyme-linked immunosorbent assay kits. Western blotting was further used to evaluate the expression of antioxidant proteins (HO-1 and cytochrome c) and apoptosis associated proteins (Bcl-2, Bax, cleaved-caspase-3, cleaved-caspase-9, and cleaved-PARP). In addition, the effects of ER on oxidative stress biomarkers and apoptosis proteins were also detected in LPS-treated H9C2 cells. Moreover, small interfering Nrf2 RNA was transfected to H9C2 cells to study the role of Nrf2 signaling in connection with the protective effects of ER. Results: Pretreatment with ER ameliorated the histopathological changes in heart tissue induced by LPS injection, increased SOD activity, and reduced MDA content, and CK-MB and LDH levels. Furthermore, ER restored the expression of Nrf-2 and HO-1 in rat hearts, attenuating apoptotic damage via up-regulation of Bcl-2 in combination with the inhibition of Bax, cytochrome c, cleaved-caspase-3 and 9, and PARP, as revealed by western blot. When Nrf2 was blocked by siRNA, the effects of ER on SOD and MDA activity, as well as the expression of the antioxidant proteins and apoptosis-associated proteins were abolished. Conclusions: We demonstrated that ER has a cardioprotective effect in LPS-induced sepsis model through modulation of the antioxidant activity and anti-apoptosis effects and this process might be regulated by Nrf2 signaling.
Ergosterol Attenuates LPS-Induced Myocardial Injury by Modulating Oxidative Stress and Apoptosis in Rats

Introduction
Sepsis is defined as a systemic inflammatory response syndrome caused by infection and clinically confirmed by the presence of bacteria or highly suspicious foci [1] . Despite significant advances in antibiotic therapy, sepsis remains an important clinical challenge, with incidence and mortality rates reaching as high as 12% and 40%, respectively [2] . Myocardial injury is a complication of sepsis induced by excess free radical production, and may cause related oxidative and apoptotic damage that may eventually lead to qualitative and quantitative myocardial alterations [3] . In recent years, a large number of specific biomarkers and accurate imaging systems that can more accurately detect cardiac injury have become available [4, 5] . However, there is still no valid way to alleviate sepsis-induced myocardial injury. Therefore, more effective drugs or means to protect against sepsisinduced myocardial injury are urgently needed.
Lipopolysaccharide (LPS), a major constituent of the bacterial cell wall, is commonly used to induce immune responses, including high-dose treatments that are capable of inducing a septic response [6] . While several mechanisms of LPS-induced myocardial injury have been hypothesized, the overproduction of autooxidation-induced cytotoxic free radicals is the most widely accepted. In this model, LPS exposure is thought to cause severe stress in cardiomyocytes, resulting in a loss of myocardial integrity due to a combination of oxygen deficiency, calcium overload, and the overproduction of free radicals [7, 8] .
The cardiomyocyte oxidative stress reaction is considered a hallmark of sepsis-induced cardiotoxicity, and enhancement of endogenous antioxidant activity has been shown to confer significant cardioprotective effects [9] . Heme oxygenase-1 (HO-1) is one of many heat-shock proteins that catalyze the degradation of heme into biliverdin, carbon monoxide, and free irons [10] . HO-1 can be activated by various stimuli, including oxidative stress, and acts as a major protective factor in cardiovascular injuries [11] . Pharmacological induction of HO-1 in rats has been shown to reduce myocardial ischemia and/or reperfusion-induced damage [12] , alleviate endotoxin-induced myocardial toxicity [13] , and optimize the therapeutic time window in myocardial infarction [14] . Notably, the mechanisms of action of some drugs against myocardial infarction injuries suggest an association between HO-1 induction and activation of transcription factor NF-E2-related factor 2 (Nrf2). Nrf-2 has been shown to regulate the bioactivities of many phase II detoxifying enzymes, including HO-1, including evidence that activation of Nrf 2/HO-1 signaling confers antiarrhythmic effects in rats after myocardial ischemia [15] .
The emerging field of phytomedicine offers significant potential for the prevention of numerous cardiovascular diseases and disorders. Many epidemiological studies have shown that terpenoid compounds extracted from fruits or vegetables may help to protect against various cardiovascular disorders. Similarly, ergosterol (ER), extracted from the fungus Agaricus campestris, has been shown to exhibit a wide range of pharmacological activities, including both anti-inflammatory and anti-oxidative effects [16] . These characteristics suggest that ER might be a potential compound for the treatment of myocardial injury. Therefore, the aim of present study was to determine the cardioprotective effects of ER in a sepsis-induced myocardial injury model and unveil the underlying mechanisms. Our study highlights an effective drug and new insights for the treatment of sepsis.
Materials and Methods
Reagents ER (purity: 97%) and dexmedetomidine (Dex) were purchased from Sigma-Aldrich (St. Louis, MO, USA). Assay kits for the detection of lactate dehydrogenase (LDH), malondialdehyde (MDA), creatine kinase (CK), and superoxide dismutase (SOD) were obtained from Nanjing Jiancheng Bioengineering Institute (Nanjing, China). Primary antibodies against Nrf-2, HO-1, Bcl-2, Bax, cytochrome c, cleaved-caspase-3, cleaved-caspase-9, and PARP were purchased from Cell Signaling Technology (Danvers, MA, USA). 
Animal
A total of fifty 8-week-old male Sprague-Dawley rats (200-250 g) were purchased from the Animal Experiment Center of Wenzhou Medical University Animal Center. The rats were housed in a climatecontrolled facility maintained at 20-25°C and 40-50% humidity, with a 12-h light/dark cycle.
Experimental design Experimental myocardial injury in rats was performed by LPS injection (15 mg/kg). Dex, which is a highly selective agonist of α2 adrenergic receptors has been proven to alleviate LPS-induced septic cardiomyopathy [17] and was used as a positive control. The experimental animals were randomly divided into five groups (n = 10) as follows: Control group, rats received 2% gum acacia suspension orally at a dose of 2 mL/kg for 5 days, followed by normal saline injected intraperitoneally on day 5; LPS group, rats received 2% gum acacia suspension at dose of 2 mL/kg for 5 days with LPS simultaneously injected intraperitoneally day 5; LPS+ Dex group, rats were treated with 2 mg/kg Dex suspension followed by LPS injection on day 5; LPS + ER (25 mg/kg, 50 mg/kg) groups, 25 or 50 mg/kg ER were given to rats orally for 5 consecutive days, and LPS was injected on day 5. Twelve hours after LPS treatment, blood samples were collected through the retro-orbital plexus. The serum specimens were centrifugated at 4, 000 × g for 15 min and stored at −80°C until needed. Thereafter, rats were anesthetized and sacrificed. Heart tissues were removed and homogenized in ice-cold phosphate buffered saline (50 mM, pH 7.4). Heart tissue homogenates from different groups were centrifuged at 12, 000 × g for 45 min at 4°C and the supernatants retained for further biochemical evaluations.
Histological examination of myocardium
Immediately after sacrifice, hearts were removed and fixed in 10% formalin solution. Samples were then prepared for sectioning and staining by standard histological methods. Processed heart sections from the left ventricles were stained with hematoxylin and eosin (H&E) and observed under light microscopy (200 ×) (Nikon, Tokyo, Japan).
Cell culture H9C2 embryonic rat heart-derived cell line was purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA); H9C2 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 5.5 mmol/L of D-glucose supplemented with 10% fetal bovine serum. Cells were maintained at 37 °C in a humidified environment consisting of 95% air and 5% CO 2 .
LPS-induced H9C2 cells protocol
H9C2 cells were cultured and divided into different groups. ER (5, 10, and 25 μM) was added into the medium for 6 h, and then cells were exposed to LPS (10 mg/mL) for 1 h. Cells and supernatants were collected for the experiments.
MTT assay for cell viability
After producing LPS-induced H9C2 cells, cell viability was evaluated by MTT assay. LPS treatment was performed as described above, after which cells were exposed to 20 μL MTT (5 mg/mL; Sigma-Aldrich) solution for 4 h. After incubation, the culture medium was discarded and 150 μL dimethyl sulfoxide was added. The absorbance values were detected at a wavelength of 570 nm by a microplate spectrophotometer. Data were evaluated as a percentage of the average absorbance relative to the control group. Experiments were conducted in triplicate. Cell viability (%) was given by the formula: (Treated/Control) × 100%.
Nrf2 silencing by siRNA H9C2 cells were inoculated in 6-well culture plates and allowed to grow to 70% confluence. Transient transfections were performed using Lipofectamine 2000 (Invitrogen Ltd., Carlsbad, CA, USA), according to the manufacturer's instructions. Specific siRNA for Nrf2 a (GGGUAAGUCGAGAAGUGUUTT) and b
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Cellular Physiology and Biochemistry (AACACUUCUCGACUUACCCTT) isoforms and scrambled control siRNAs were designed by GenePharma (Shanghai, China). For each reaction, 5 μL siRNA, 5 μL lipofectamine 2000, and 95 μL serum-free medium (Opti-MEM; Invitrogen) were mixed at room temperature and incubated for 20 min. Next, 800 μL of Opti-MEM medium was added drop-wise to each well, and the resulting mixture was added to the H9C2 cells. After transfection for 6 h, cell culture medium was replaced, and cells were further incubated for 24 h before exposure to LPS. The knockdown efficiency was validated by the analysis of myocardial injury markers and western blot.
Estimation of myocardial injury markers
The levels of CK, MDA, LDH, and SOD in serum, as well as the concentration of SOD and MDA in the myocardial tissue and cell supernatant, were detected.
Western blot analysis
Protein expression in myocardial tissue and H2C9 cells was determined by western blot. Briefly, myocardial tissues and cells were collected and homogenized in ice cold RIPA buffer with 0.1% phenylmethylsulfonyl fluoride, and centrifuged at 13, 000 × g for 20 min; the supernatants were collected for further analysis. Protein concentrations were determined by bovine serum albumin assay. Equal amounts of protein were separated by 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and electroblotted onto polyvinylidene fluoride membranes. After blocking with 5% non-fat milk for 1.5 h at 37°C, the membranes were incubated with the primary antibody overnight at 4°C, followed by peroxidaseconjugated secondary antibody for 1 h at room temperature. Immunoreactive protein bands were visualized using a Tanon 5200 Chemiluminescence imaging system (Tanon, Shanghai, China).
Statistical analysis
All data are presented as the mean ± standard deviation. In the case of mean comparisons, the data were analyzed by one-way analysis of variance with Tukey's multiple comparison tests in GraphPad Prism 5.0 software (GraphPad Inc., La Jolla, CA, USA). P < 0.05 was considered statistically significant.
Results
ER attenuates the myocardial injury of rats in LPS-induced sepsis model
To test the effect of ER (Fig. 1) on LPS-induced myocardial injury, we first examined the histological changes in the rats' hearts. H&E staining results are shown in Fig. 2 . There was a normal myofibrillar structure branched appearance, and striation and continuity with adjacent myofibrils in the control group. However, rat myocardium samples from the LPS-challenged rats had markedly swollen myocardial cells, loss of transverse striations, and a greater amount of infiltrating inflammatory cells. Samples from the rats pretreated with Cell
ER showed normal and preserved cardiomyocyte histology. In addition, histological sections from the high-dose ER group (50 mg/kg) rats showed nearly normal myofiber structure with significant striations and a small number of inflammatory cells. Thus, ER effectively mitigated the reduced cardiac performance in rats induced following LPS.
ER increased SOD activity and decreased the formation of MDA, CK-MB, and LDH in LPS-induced sepsis rats
As myocardial marker enzymes, myocardial injury parameters CK-MB and LDH are usually used to measure the severity of ischemic heart disease. In Fig. 3 , the expression of CK-MB and LDH appeared to be significantly increased in the LPSinduced sepsis model group compared with the control group. However, pretreatment with ER dramatically reduced CK-MB and LDH levels compared with the model group in a dose-dependent manner. Meanwhile, SOD (Fig. 3C) and MDA (Fig. 3D ) activities in serum were studied to verify the antioxidative activities of ER. LPS markedly decreased SOD activity and increased MDA activity. Pretreatment with ER intriguingly reversed the activity of MDA and SOD. |Moreover, the concentrations of SOD and MDA in the myocardium were also tested (Fig. 4) . Similar effects of ER were observed. Taken together, ER could attenuate myocardial injury induced by LPS, and this might due to its anti-oxidative activities.
ER decreased the oxidative stress and inhibited the apoptosis in hearts tissues induced by LPS
The effect of ER on the expression of oxidative stress and apoptosis-related . LPS clearly increased the levels of Bax, cytochrome c, cleaved-caspase-3 and 9, and PARP, and decreased Bcl-2, Nrf2, and HO-1 compared with the control group. In contrast, the administration of ER reversed the effects of LPS on oxidative stress and apoptosis-related proteins.
ER increased the cell viability of rat cardiomyoblastoma cells in vitro
To further study the underlying mechanisms, we established an LPS-induced sepsis cell model with H9C2 cell line in vitro. MTT results revealed that LPS decreased the viability of H9C2 cells compared with that of the control group, and, as expected, this was alleviated by ER (5, 10, and 25 μM) to different degrees. Our results indicated that the loss of viability induced by LPS in H9C2 cells was effectively recovered by the cytoprotective effects of ER (Fig. 6) .
ER increased the expression of SOD and decreased the level of MDA in vitro and these effects were blocked by Nrf2 siRNA
To investigate alterations triggered by LPS injury, SOD and MDA levels were tested in vitro. As expected, increased amounts of MDA and decreased SOD activities were significantly exhibited in the LPS damaged group, but these alterations were alleviated after ER intervention (5, 10, and 20 μM) in a concentration-dependent manner.
To further characterize the essential role of Nrf2 in the protection of ER cells against LPS-induced injury, a Nrf2 siRNA transfection experiment was carried out to knockdown Nrf2 expression in H9C2 cells. The upregulation of Nrf2 expression by ER in H9C2 cells was significantly decreased by Nrf2 siRNA. The effects of ER on the expression on SOD and MDA were completely blocked by Nrf2 silencing. These results showed that ER exerted its protective effects via the syntheses and the release of SOD and MDA in LPS-stimulated H2C9 cells, and this process might be regulated by Nrf2 signaling (Fig. 7) .
The effects of ER on oxidative stress and apoptosis-related protein expression were regulated by Nrf2 signaling
As is shown in Fig. 8 , in response to LPS injury, the expression of Bax, cytochrome c, cleaved-caspase-3 and 9, and PARP increased but the protein levels of Bcl-2, Nrf2, and HO-1 decreased. Treatment with ER (5, 10, and 25 μM) effectively restored these alterations. Furthermore, when the Nrf2 expression was silenced, ER intervention could not inhibit the overexpression of Bax, cytochrome c, cleaved-caspase-3/9, or PARP induced by LPS. Moreover, the induction of Bcl-2 and HO-1 expression via ER were obviously reduced by 
Nrf2 knockdown. Taken together, our findings indicated that ER prevented LPS-induced cell apoptosis via activation of the Nrf2 signaling pathway in vitro.
Discussion
The results of our study demonstrated that ER significantly protected rats against myocardial injury induced by sepsis by increasing antioxidant activity in the heart and inhibiting cardiac apoptosis. Our research also found that ER effects on sepsis-induced myocardial injury were blocked by Nrf2 knockdown, suggesting that ER attenuated cardiotoxicity in a Nrf2 signaling-related manner.
Increasing evidence has suggested that morphological and functional alterations in the myocardium, along with necrosis of the heart muscle induced by a supramaximal dose of LPS, closely imitates myocardial infarction-like pathological features observed in clinical patients [18, 19] . Thus, LPS-induced endotoxemia cardiac injury model was used in this study. We also limited our animal model to male rats to avoid the effects of estrogen, which has been shown to protect against ischemic injury and inhibit arteriosclerosis and myocardial hypertrophy [20, 21] . This in vivo model has been successfully validated as shown by alterations in the sarcolemmal integrity of myocardial cells during histological examinations and serum elevations of CK-MB and LDH enzymes. Our results showed that ER ameliorated myocardial pathological injury, reduced the heart rate, and decreased CK-MB and LDH enzyme levels and these signs are consistent with decreased pathological events.
Sepsis-induced cardiotoxicity is characterized by overproduction of free radicals and depletion of antioxidants in the cardiac defence system, leading to an imbalance between oxidative and antioxidative factors [22] [23] [24] . The levels of SOD and MDA activity are among the principal pathophysiological parameters for evaluating free radical metabolism. MDA, often used as an indicator of oxidative damage [25] , is typically used to assess the degree of lipid peroxidation in an organism, but is also used as an indirect measure of cell damage. SOD, an important myocardial antioxidant enzyme, is able to scavenge oxygen free radicals, thereby converting superoxide radicals into hydrogen peroxide, which is subsequently metabolized into oxygen and water [26, 27] . Here, we showed that ER inhibited LPS-induced MDA expression and enhanced SOD activity both in vivo and in vitro. Pretreatment with ER also significantly attenuated the effects of LPS on CK-MB and LDH in the serum of treated rats. Similar effects were seen in LPS-treated H9C2 cells. Taken together, these results demonstrated that ER conferred cardioprotective effects against myocardial ischemia in a dose-dependent manner, likely due to its anti-oxidative properties. Nrf-2/HO-1 signaling is a major intracellular mechanism used to combat oxidative stress [28, 29] . The transcription factor Nrf2 is expressed on exposure to oxidative stress, where it encodes a battery of antioxidant and cytoprotective enzymes, including heme HO-1 and glutathione S-transferase, which together participate in various detoxification, antioxidation, and anti-apoptosis processes [30, 31] . Elevated expression of HO-1 confers strong antioxidative stress and cytoprotective effects, partly by up-regulating ferritin, which results in increased free iron in the extracellular space [32] . In the present study, Nrf2 and HO-1 activities were significantly decreased in the heart tissues of LPS-treated rats compared with those of controls. Increased HO-1 levels were consistent with the changes in Nrf2 expression seen in groups pre-treated with ER, indicating that their cardioprotective effects could be attributable to Nrf2/HO-1 mediated anti-oxidative signaling. These observations suggest that ER intervention may enhance cardiomyocyte resistance to oxidative stress via activation of the Nrf2/HO-1 signaling pathway.
Beyond its antioxidative activity, ER also exhibited anti-apoptotic effects. In myocardial infarction, wall thinning, net increases in extracellular myocardium matrix accumulation, and myocyte hypertrophy have been shown to trigger complex signaling cascades, resulting in cardiomyocyte apoptosis and necrosis [33, 34] . Recent studies have proved that cytochrome c plays an intermediate role in apoptosis, a controlled form of cell death used to kill cells in the process of development or in response to infection or DNA damage. It is also needed in the mitochondria to limit the production of O 2-and H 2 O 2 [35, 36] . Pretreatment with ER inhibited apoptosis in the myocardium and increased the cell viability of LPS-treated H9C2 cells. Western blot results also showed that ER increased the expression levels of antiapoptotic proteins (Bcl-2) and decreased the pro-apoptotic apoptosis associated proteins (Bax, cytochrome c, cleaved-caspase-3, cleaved-caspase-9, and cleaved-PARP). These results indicated that the cardioprotective effects of ER were also attributable to its anti-apoptotic properties.
To further investigate whether the antioxidant and anti-apoptosis effects of ER were regulated by Nrf2 signaling, we silenced Nrf2 expression by siRNA in LPS-treated H9C2 cells. Interestingly, down-regulation of Bax, cytochrome c, and cleaved-caspase-3 and 9 and upregulation of PARP, Bcl-2, and HO-1 expression caused by ER were largely reversed. These observations further indicated the involvement of Nrf2 in myocardial infarction and suggest that Nrf2 up-regulation might be a feasible strategy for the treatment of ischemic cardiac damage.
Taken together, the data presented have shown that antioxidant therapy targeting Nrf2 signaling may protect against myocardial infarction injury. ER significantly elevated Nrf2 mediated anti-oxidative activities, both in vitro and in vivo, and resulted in significant protection against cardiomyocyte apoptosis. ER, via its function as a Nrf2 activator, should therefore be considered as a potential therapeutic agent for the prevention of myocardial injury. Here, we report for the first time that ER pretreatment could preserve heart function by increasing cardiac antioxidant expression and reducing apoptosis in cardiomyocytes. Further studies will be necessary to validate and expand on these initial findings.
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